Laboratorios Richmond S.A.C.I.F. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was ARS 173.61 million compared to ARS 142 million a year ago.
For the nine months, net income was ARS 717.86 million compared to net loss of ARS 192.53 million a year ago. Basic earnings per share from continuing operations was ARS 8.89 compared to basic loss per share from continuing operations of ARS 2.38 a year ago. Diluted earnings per share from continuing operations was ARS 8.89 compared to diluted loss per share from continuing operations of ARS 2.38 a year ago.